The Latest Cardiac and Vascular News
AMSTERDAM, Aug. 22, 2018 /PRNewswire/ — Royal Philips (NYSE : PHG , AEX: PHIA), a global leader in health technology, today introduced the EPIQ CVx cardiovascular ultrasound system. Built on the powerful EPIQ ultrasound platform, EPIQ CVx is specifically designed to increase diagnostic confidence and simplify workflow for clinicians, giving them more time to interact with their patients […]
AMSTERDAM and PHILADELPHIA, June 25, 2018 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is highlighting its portfolio of molecular imaging solutions at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 Annual Meeting in Philadelphia, PA. With innovations such as Time-of-Flight PET and digital PET/CT, Philips is continuing to […]
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire EPD Solutions, an innovator in image-guided procedures for cardiac arrhythmias (heart rhythm disorders). EPD’s cardiac imaging and navigation system [1] helps electrophysiologists navigate the heart by generating […]
AMSTERDAM and VAIL, Colo., June 1, 2018 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it will be providing Philips HeartStart Onsite automated external defibrillators (AEDs) to Vail and Beaver Creek Mountains to create a cardiac arrest response system in collaboration with Starting Hearts and medic assist. To celebrate this, a launch event […]
AMSTERDAM, March 23, 2018 /CNW/ – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology has delivered a broad range of health technology solutions to the University of Ottawa Heart Institute (UOHI) – Canada’s largest and foremost heart health centre dedicated to understanding, treating, and preventing heart disease. Today, […]
AMSTERDAM, March 15, 2018 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ProxiDiagnost N90, its newest premium Digital Radiography-Fluoroscopy (DRF) system. With its ability to perform both nearby fluoroscopy and digital […]
AMSTERDAM and ORLANDO, Florida, March 10, 2018 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced health economic results from the DEFINE FLAIR clinical trial comparing cost-effectiveness between instant wave-free ratio (iFR) and fractional flow reserve (FFR) in the guidance of treatment of ischemic heart […]
Comprehensive informatics and imaging solution features enhanced security protocols to meet industry-leading standards Improved interoperability and standardization increases scalability across the hospital enterprise to help improve efficiency and quality AMSTERDAM and LAS VEGAS, March 5, 2018 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of IntelliSpace Cardiovascular 3.1, […]
AMSTERDAM and LAS VEGAS, Sept. 14, 2017 /PRNewswire/ — Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating the efficacy of Philips Spectranetics’ Stellarex .035″ drug-coated balloon (DCB) for peripheral arterial disease (PAD) in comparison to uncoated balloon angioplasty. Marianne […]
Philips subsidiary Spectranetics recalls Bridge occlusion balloon AUGUST 31, 2017 BY BRAD PERRIELLO , MassDevice Royal Philips (NYSE:PHG) subsidiary Spectranetics recalled its Bridge occlusion balloon after receiving reports of blocked guidewire lumens. The Bridge device is used to temporarily block the superior vena cava for emergency control of hemorrhage. Spectranetics said the August 25 recall was […]
